Nanci Caldwell
Known title: DirectorCIK: 0001232403
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Fitch upgrades Equinix outlook to positive on capital discipline. Fitch upgraded Equinix's outlook to positive, citing the company's strong capital discipline and scale. This move aligns with broader market attention on Equinix as a key beneficiary of rising AI data center demand. The neutral technical backdrop, with the stock near support, provides context for this fundamental shift.
Transaction History
| PCOR | ▲ Buy | Grant | 4,712 | $0 | 6/4/2026 | View on chart |
| PCOR | ▲ Buy | Grant | 3,049 | $0 | 6/5/2025 | View on chart |
| PCOR | ▼ Sell | Open Market | 1,787 | $117K | 6/10/2024 | View on chart |
| PCOR | ▲ Buy | Grant | 2,887 | $0 | 6/6/2024 | View on chart |
| EQIX | ▲ Buy | Option Exercise | 353 | $0 | 5/28/2024 | View on chart |
| PCOR | ▼ Sell | Open Market | 1,169 | $85K | 2/21/2024 | View on chart |
| PCOR | ▼ Sell | Open Market | 4,299 | $320K | 2/21/2024 | View on chart |
| PCOR | ▼ Sell | Open Market | 3,802 | $280K | 2/21/2024 | View on chart |
| PCOR | ▼ Sell | Open Market | 9,270 | $695K | 2/9/2024 | View on chart |
| PCOR | ▼ Sell | Open Market | 9,270 | $649K | 12/26/2023 | View on chart |
| PCOR | ▼ Sell | Open Market | 2,036 | $130K | 6/8/2023 | View on chart |
| PCOR | ▲ Buy | Grant | 3,574 | $0 | 6/7/2023 | View on chart |
| EQIX | ▲ Buy | Option Exercise | 364 | $0 | 5/25/2023 | View on chart |
| PCOR | ▲ Buy | Grant | 4,072 | $0 | 6/3/2022 | View on chart |
| EQIX | ▲ Buy | Option Exercise | 339 | $0 | 5/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Procore Shares Rise After Cantor Overweight Endorsement
Cantor Fitzgerald reaffirmed its overweight stance on Procore Technologies, keeping a $65 price target. The stock has risen in the market, trading above its 200‑day moving average and near the support level at $55.26. Analysts maintain a target range of $55 to $88, with an average of $68.19.
Procore Shares Rise After Cantor Overweight Endorsement. Cantor Fitzgerald reaffirmed its overweight stance on Procore Technologies, keeping a $65 price target. The stock has risen in the market, trading above its 200‑day moving average and near the support level at $55.26. Analysts maintain a target range of $55 to $88, with an average of $68.19.